Mead Johnson Board Increases Dividend by 13 Percent
    
      The dividend will be paid on 
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company’s mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s “Enfa” family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition. For more information, visit meadjohnson.com.
Forward-Looking Statements
      Certain statements in this news release are forward looking as
      defined in the Private Securities Litigation Reform Act of 1995. These
      statements, which are identified by words such as “expects,” “intends”
      and “believes,” involve certain risks, uncertainties and assumptions
      that may cause actual results to differ materially from expectations as
      of the date of this news release. These risks include, but are not
      limited to: (1) the ability to sustain brand strength, particularly the
      Enfa family of brands; (2) the effect on the company's reputation of
      real or perceived quality issues; (3) the adverse effect of commodity
      costs; (4) increased competition from branded, private label, store and
      economy-branded products; (5) the effect of an economic downturn on
      consumers' purchasing behavior and customers' ability to pay for
      product; (6) inventory reductions by customers; (7) the adverse effect
      of changes in foreign currency exchange rates; (8) the effect of changes
      in economic, political and social conditions in the markets where we
      operate; (9) legislative, regulatory or judicial action that may
      adversely affect the company's ability to advertise its products or
      maintain product margins; (10) the possibility of changes in the Women,
      Infant and Children (WIC) program, or participation in WIC; and (11) the
      ability to develop and market new, innovative products. For additional
      information on these and other factors, see the risk factors identified
      in the company's periodic reports, including the annual report on Form
      10-K for 2012, quarterly reports on Form 10-Q and current reports on
      Form 8-K, filed with, or furnished to, the 
Source: 
      Mead Johnson Nutrition Company
Investors:
Kathy
      MacDonald, (847) 832-2182
kathy.macdonald@mjn.com
Media:
Christopher
      Perille, (847) 832-2178
chris.perille@mjn.com
    
2/27/2013